Milestone Scientific Schedules Second Quarter 2020 Conference Call

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LIVINGSTON, NJ / ACCESSWIRE / August 13, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, August 17, 2020 to discuss the Company’s financial results for the second quarter ended June 30, 2020, as well as the Company’s corporate progress and other developments.

The conference call will be available on the Company’s website at www.milestonescientific.com, or via telephone by dialing toll free 877-407-0778 for U.S. callers, or +1 201-689-8565 for international callers. A webcast will also be archived on the Company’s website and a telephone replay of the call will be available approximately one hour following the call, through Monday, August 31, 2020, and can be accessed by dialing 877-481-4010 for U.S. callers, or +1 919-882-2331 for international callers and entering the pass code 36611.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.

Contact:

David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

SOURCE: Milestone Scientific, Inc.

View source version on accesswire.com:
https://www.accesswire.com/601466/Milestone-Scientific-Schedules-Second-Quarter-2020-Conference-Call

Staff

Recent Posts

FendX Technologies Announces Fully Subscribed Closing of Non-Brokered Private Placement

Oakville, Ontario--(Newsfile Corp. - March 13, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

2 hours ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Received FDA Clearance for the HeartBeam System – an At-Home, High-Fidelity Heart Monitoring Technology Commenced…

5 hours ago

TE Connectivity announces 9% increase in quarterly cash dividend to $0.71

Shareholders reelect all 12 members to board of directors during annual general meeting GALWAY, Ireland,…

5 hours ago

NextPlat Changes the Date of its 2024 Financial Results Report and Investor Conference Call to Monday, March 24, 2025

COCONUT GROVE, Fla., March 13, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or…

5 hours ago

Tired of Late-Night Dental Paperwork? DentScribe.ai’s New Agentic AI Let’s Dentists Focus on Patients, Not Notes

SUNNYVALE, Calif., March 13, 2025 /PRNewswire/ -- Imagine finishing your last appointment of the day and…

5 hours ago

Healthcare Sector Faces Urgent Cybersecurity Wake-Up Call; Info-Tech Research Group Releases Critical Insights for Security Leaders

In the wake of the recent Change Healthcare/UHC data breach, critical vulnerabilities in healthcare have…

5 hours ago